clinical practice guidelines are the most important and valid guidelines for treatment of diseases, and are developed through experts consensus on a subject, considering the highest available evidence (systematic reviews, meta-analyses, and randomized controlled trials). we briefly review the latest evidence-based guidelines for the treatment of two common diseases of acne (provided by european...

Minoxidil is a piperidine-pyrimidine derivative and potent vasodilator approved orally for severe hypertension topically androgenetic alopecia (AGA).[1][1] The minimum plasma threshold induction of hair growth an order magnitude below the required any hemodynamic

The treatment of hair loss diseases is sometimes difficult because of insufficient efficacy and limited options. However, recent advances in understanding of the pathophysiology and development of new remedies have improved the treatment of refractory hair loss conditions. In this article, an update on the management of hair loss diseases is provided, especially focusing on recently reported th...

<p class="abstract">Androgenetic alopecia is a patterned hair loss disorder affecting approximately 73% of men and 57% women in their lifetime, this affection can cause psychological effects like low self-stem depression diminishing the quality life. Currently, finasteride minoxidil are only two drugs approved by food drug administration (FDA), devices low-level laser therapy FDA cleared....